At the center of the discovery is a molecule called CysLTR1, which is best known for its role in asthma and inflammation.
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...
A drug widely used to treat asthma and allergies may also help fight aggressive cancers, reports a new Northwestern Medicine ...